Moderna
MRNA
#1327
Rank
ยฃ10.93 B
Marketcap
ยฃ28.41
Share price
0.90%
Change (1 day)
-64.64%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Moderna (MRNA) - Total debt

Total debt on the balance sheet as of September 2024 : ยฃ1.10 Billion

According to Moderna 's latest financial reports the company's total debt is ยฃ1.10 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Moderna - Total debt on balance sheet (from 2017 to 2024)

Total debt by year

Year Total debt Change
2023-12-31ยฃ0.97 B-1.64%
2022-12-31ยฃ0.99 B46.17%
2021-12-31ยฃ0.67 B290.29%
2020-12-31ยฃ0.17 B72.25%
2019-12-31ยฃ0.10 B282.6%
2018-12-31ยฃ26.38 M127.3%
2017-12-31ยฃ11.6 M14.58%
2016-12-31ยฃ10.13 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
ยฃ0.38 M-99.96%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ31.15 B 2,714.10%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ15.17 M-98.63%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ1.06 B-3.92%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ26.27 B 2,273.36%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
ยฃ0.41 B-62.32%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ29.21 B 2,538.45%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA